-The Hindu Centre for Politics and Public Policy Prime Minister Narendra Modi's announcement demonetising high denomination notes on November 8, 2016, will do little to address the prime objective of flushing out black money but will adversely affect the economy in the short term, especially the informal sector, which is predominant in India, says M. Govinda Rao, a Member of the Fourteenth Finance Commission and Emeritus Professor, National Institute of Public...

-PTI Unions claimed that the government has not formally invited them to the summit, but has appointed BMS to coordinate with them for the event New Delhi: The 2-day BRICS (Brazil, Russia, India, China and South Africa) Labour and Employment Ministerial meeting will commence in New Delhi on Tuesday but the Central Trade Unions (CTUs) have decided to boycott the event. The meeting will deliberate on issues including job creation and social security...

-TheGuardian.com Hardworking women in India care for family members, cook, clean, garden, sew and farm without getting paid. When will official statistics recognise this? Women’s participation in work is an indicator of their status in a society. Paid work offers more opportunities for women’s agency, mobility and empowerment, and it usually leads to greater social recognition of the work that women do, whether paid or unpaid. Where women’s work participation rates are relatively...

-The Hindu In the area of intellectual property, public health and access to medicines, the Narendra Modi government should consider its independence to be of the utmost importance. Strong government leadership as well as flexible intellectual property systems are needed in order to effectively combat drug-resistant tuberculosis (DR-TB) and HIV and also antimicrobial resistance and non-communicable diseases. This is true not only for India but also countries which rely on affordable generic...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...